August 2018 PMID 30092894

Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea.

Donghee Kim, Aijaz Ahmed, Clete Kushida

Full text PDF Download social card

Mentions

Peak: 1 in Nov 2019

across 2 sources since Nov 2019

Extended reach

330,166

potential audience

Total likes

5,498

Video views

322,916

Mentions per month

Nov 2019 – Apr 2025

Where it's discussed

YouTube2 videos
X / Twitter1 posts

AI synopsis

What people are saying

The overall tone indicates support and interest, with comments such as emphasizing CPAP's potential to improve liver conditions and noting the importance of adherence, like 'consistent use shows better outcomes.' The words and tone reflect a shared curiosity and cautious optimism, framing the research as an important step in managing NAFLD in sleep apnea patients.

AgreementModerate agreement

Most discussions express support for the findings, highlighting the potential benefits of CPAP in improving liver health for patients with sleep apnea and NAFLD.

InterestModerate interest

The discussions show moderate interest, with participants engaging in shared curiosity about the therapy's implications but not delving deeply into technical details.

EngagementModerate engagement

Comments include references to personal experiences and general discussions about treatment adherence, indicating a moderate level of engagement.

ImpactModerate impact

The discussions suggest the publication could influence clinical practices and patient compliance, though the overall impact isn't portrayed as revolutionary.

Abstract in brief

The study found that treating obstructive sleep apnea (OSA) with continuous positive airway pressure (CPAP) led to significant improvements in liver-related enzymes and reductions in fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).
Patients who used CPAP consistently for more than 3 months showed greater biochemical improvement, indicating that good adherence to treatment is linked to better liver health outcomes.
Overall, the results suggest that CPAP therapy may be an effective way to help improve liver condition in patients with both OSA and NAFLD, especially when used regularly.]

Read the full abstract

All mentions

Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease Risk in Women

This study shows that women with polycystic ovary syndrome, especially those with higher androgen levels, are at increased risk of developing nonalcoholic fatty liver disease, highlighting the need for targeted liver…

دکتر بابک جمالیان · Apr 5, 2025 238,856 views

Polycystic Ovary Syndrome and Liver Disease Risk: A Longitudinal Study

This study shows that women with polycystic ovary syndrome, especially those with higher levels of androgens like testosterone and SHBG, have an increased risk of developing nonalcoholic fatty liver disease, based on a…

دکتر بابک جمالیان · Mar 13, 2025 84,060 views

Sleep Research

@SleepResearch_ · X

Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea. https://t.co/iWB5sVvNOI

Nov 28, 2019 · 7,251 followers View post →